117th Congress · HOUSE BILLBILL

H.R. 7658 — To amend the Federal Food, Drug, and Cosmetic Act to reauthorize the Critical Path Public-Private Partnerships.

“To amend the Federal Food, Drug, and Cosmetic Act to reauthorize the Critical Path Public-Private Partnerships.”

Health

Introduced May 3, 2022

Last action May 3, 2022

Pipeline · Bill → Law

Step 1

Introduced

May 3, 2022

Step 2

Referred

May 3, 2022

E&C

Step 3

Committee

Step 4

House floor

Step 5

Senate

Step 6

Resolve Changes

Step 7

Signed

SummaryNo summary available

No CRS summary available for this bill.

Provisions · 1 sectionsIntroduced in House

Timeline · 2 actions

May 3, 2022

Introduced in House

May 3, 2022

Referred to the House Committee on Energy and Commerce.